首页> 美国卫生研究院文献>Nutrients >Regular Consumption of Lipigo® Promotes the Reduction of Body Weight and Improves the Rebound Effect of Obese People Undergo a Comprehensive Weight Loss Program
【2h】

Regular Consumption of Lipigo® Promotes the Reduction of Body Weight and Improves the Rebound Effect of Obese People Undergo a Comprehensive Weight Loss Program

机译:Lipigo®定期消费促进体重的减少提高肥胖人民接受全面减肥计划的反弹效果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Obesity is a global public health problem. Objective: To evaluate the effect of the regular consumption of the product Lipigo on body weight and rebound effect on overweight/obese subjects undergoing a comprehensive weight loss program. Methods: A randomized, parallel, double-blind, placebo-controlled clinical trial was conducted with male and female subjects presenting a BMI 25–39.9 kg/m . All subjects underwent a comprehensive weight loss program (WLP) for 12 weeks, which included an individualized hypocaloric diet, physical activity recommendations, nutritional education seminars, and three times a day consumption of the product Lipigo or Placebo. After-WLP, subjects continued the treatment for 9 months to assess rebound effect. Body weight (BW), BMI, and body composition were measured at the beginning and the end of the WLP, and in the follow-up. Results: A total of 120 subjects (85% women) 49.0 ± 9.5 years old and with a BW of 81.57 ± 13.26 kg (BMI 31.19 ± 3.44 kg/m ) were randomized and 73 subjects finished the study. At the end of the WLP, there was a tendency toward reduced BW ( = 0.093), BMI ( = 0.063), and WC ( = 0.059) in the treated group. However, subjects with obesity type 1 (OB1) from the treated group significantly reduced body weight (−5.27 ± 2.75 vs. −3.08 ± 1.73 kg; = 0.017) and BMI (−1.99 ± 1.08 vs. −1.09 ± 0.55 kg/m ; = 0.01) compared with placebo. They also presented a minor rebound effect after 9 months with product consumption (−4.19 ± 3.61 vs. −1.44 ± 2.51 kg; 0.026), minor BMI (−1.61 ± 1.43 vs. −0.52 ± 0.96 kg/m ; = 0.025) and tended to have less fat-mass (−3.44 ± 2.46 vs. −1.44 ± 3.29 kg; = 0.080) compared with placebo. Conclusions: The regular consumption of the product Lipigo promotes the reduction of body weight and reduces the rebound effect of obese people after 52 weeks (12 months), mainly in obesity type 1, who undergo a comprehensive weight loss program.
机译:肥胖是全球公共卫生问题。目的:评价常规消费产品Lipigo对体重和反弹效果对综合体重减轻计划的超重/肥胖受试者的影响。方法:用雄性和女性受试者进行随机,平行,双盲,安慰剂对照临床试验,呈现BMI 25-39.9 kg / m。所有受试者都经历了12周的全面减肥计划(WLP),其中包括个性化的低高价饮食,身体活动建议,营养教育研讨会,产品利润或安慰剂的日期消耗量为3次。 WLP后,受试者继续治疗9个月以评估反弹效果。在WLP的开始和末端测量体重(BW),BMI和身体组成,并在随访中测量。结果:共有120名受试者(85%妇女)49.0±9.5岁,BW为81.57±13.26公斤(BMI 31.19±3.44 kg / m),并完成了73项受试者的研究。在WLP的末端,在治疗组中存在降低BW(= 0.093),BMI(= 0.063)和WC(= 0.059)的趋势。然而,来自治疗组的肥胖型1(OB1)的受试者显着减少了体重(-5.27±2.75 Vs. -3.08±1.73kg; = 0.017)和BMI(-1.99±1.08与-1.09±0.55 kg / m与安慰剂相比,= 0.01)。它们在9个月后,产品消耗(-4.19±3.61与-1.44±2.51kg; 0.026),次要BMI(-1.61±1.43与-0.52±0.96kg / m; = 0.025)和与安慰剂相比,往往具有较少的脂肪质量(-3.44±2.46与-1.44±3.29kg; = 0.080)。结论:产品利润的常规消费促进体重减少,减少52周(12个月)后肥胖人的反弹效果,主要是肥胖型1,后者进行全面减肥计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号